16

rezultati

Beseda/besede
Vrsta publikacije
Politično področje
Avtor
Ključna beseda
Datum

What if we could fight drug addiction with digital technology?

12-04-2019

What if digital technology could assist drug addiction recovery by online counselling, monitoring behaviour, and real-time interventions in patients’ everyday lives? Assistance at a distance: how could clinicians, health personnel, friends and family support a patient suffering from drug addiction via digital technology?

What if digital technology could assist drug addiction recovery by online counselling, monitoring behaviour, and real-time interventions in patients’ everyday lives? Assistance at a distance: how could clinicians, health personnel, friends and family support a patient suffering from drug addiction via digital technology?

Brain: New approach to brain diseases

15-01-2019

This report summarises the presentations and discussion of the Workshop on “The Brain – A New Approach to Brain Diseases” held on 21 November, 2018 at the European Parliament. The purpose of the workshop was to highlight current and new approaches to the treatment of brain diseases, including diagnosis and rehabilitation. The panel of expert speakers addressed both clinical and policy issues and highlighted the need for dialogue and co-operation between scientists, industry and society.

This report summarises the presentations and discussion of the Workshop on “The Brain – A New Approach to Brain Diseases” held on 21 November, 2018 at the European Parliament. The purpose of the workshop was to highlight current and new approaches to the treatment of brain diseases, including diagnosis and rehabilitation. The panel of expert speakers addressed both clinical and policy issues and highlighted the need for dialogue and co-operation between scientists, industry and society.

Zunanji avtor

Richard Twyman

What if mini-brains could help us understand dementia?

05-12-2017

Organoids are artificially grown organs that mimic the properties of real organs. What new possibilities for treating diseases, drug development, and personalised and regenerative medicine do organoids provide?

Organoids are artificially grown organs that mimic the properties of real organs. What new possibilities for treating diseases, drug development, and personalised and regenerative medicine do organoids provide?

Personalised Medicine - Current Status

30-11-2017

Personalised Medicine (PM - sometimes also termed as precision or stratified medicine) refers to the grouping of patients based on risk of disease, or response to therapy, using advanced diagnostic tests or techniques. The briefing gives an account of the initiatives taken at the EU to foster the advancement of this approach into daily practice.

Personalised Medicine (PM - sometimes also termed as precision or stratified medicine) refers to the grouping of patients based on risk of disease, or response to therapy, using advanced diagnostic tests or techniques. The briefing gives an account of the initiatives taken at the EU to foster the advancement of this approach into daily practice.

Complementary and alternative therapies for patients today and tomorrow

23-10-2017

This report summarises the presentations and discussions of a workshop on “Complementary and Alternative Therapies for Patients Today and Tomorrow”, held at the European Parliament in Brussels on Monday 16 October 2017. The aim of the workshop was to provide background and technical information and advice to the members of the ENVI Committee on the latest findings and trends in the field of complementary and alternative therapies. The current state of play of complementary and alternative therapies ...

This report summarises the presentations and discussions of a workshop on “Complementary and Alternative Therapies for Patients Today and Tomorrow”, held at the European Parliament in Brussels on Monday 16 October 2017. The aim of the workshop was to provide background and technical information and advice to the members of the ENVI Committee on the latest findings and trends in the field of complementary and alternative therapies. The current state of play of complementary and alternative therapies in Europe was highlighted during the first part of the workshop. Presentations focused on CAM in practice and academic research. The second part of the workshop focused on the policy and legal framework in Europe and the integration of CAM into EU healthcare systems.

Zunanji avtor

Alexandra SCHNEIDERS, Matteo MASCOLO, Alicia MCNEILL, Meena FERNANDES

The Fight against Cancer Is a Team Sport: The Role of Education and Sport

09-12-2016

This document summarises the presentations and discussions taking place at the workshop organised by Policy Department A on the role of education and sport in the fight against cancer, held at the European Parliament in Brussels in July 2016. The aim of the workshop for the Committee on Environment, Public Health and Food Safety was to provide background information and highlight ways in which sport and physical activity can be promoted to help reduce the overall impact of cancer. Firstly the scientific ...

This document summarises the presentations and discussions taking place at the workshop organised by Policy Department A on the role of education and sport in the fight against cancer, held at the European Parliament in Brussels in July 2016. The aim of the workshop for the Committee on Environment, Public Health and Food Safety was to provide background information and highlight ways in which sport and physical activity can be promoted to help reduce the overall impact of cancer. Firstly the scientific evidence for the link between physical (in)activity and cancer was presented. Risk reductions were discussed, as well as the risks of inactivity, followed by recommendations on improving activity levels. The evidence so far is strong for colon, breast and endometrial cancers. Secondly the focus was on policy initiatives to fight against cancer through education, sport, and physical activity, with discussions on strategies and actions of the European Commission and the WHO. Finally, presentations were given by organisations set up to promote activity during or after cancer treatments, along with recommendations to prevent cancer.

Zunanji avtor

Alojz PETERLE (MEP, EP), Michael LEITZMANN (University of Regensburg, DE), Margo MOUNTJOY (International Olympic Committee), Yves Le LOSTECQUE (DG EAC, European Commission), Susanna KUGELBERG (World Health Organisation), Wendy YARED (European Cancer Leagues), Jaka JAKOPIČ (Ambassador of Movember Movement, SI), Olivier LAPLANCHE (CAMI, FR) and Petra THALLER (Outdoor against Cancer)

Living with a Neurological Brain Disorder: Taking Control of Your Life

14-10-2016

This report summarises the presentations and discussions of the workshop on the neurological brain disorders, held at the European Parliament in Brussels on Wednesday 12 October 2016. The aim of the workshop was to provide background information about the main characteristics of neurological brain disorders, as well as to identify new strategies and innovative tools to better support the prevention and treatment of these diseases. The latest data, trends, and challenges in the field of neurological ...

This report summarises the presentations and discussions of the workshop on the neurological brain disorders, held at the European Parliament in Brussels on Wednesday 12 October 2016. The aim of the workshop was to provide background information about the main characteristics of neurological brain disorders, as well as to identify new strategies and innovative tools to better support the prevention and treatment of these diseases. The latest data, trends, and challenges in the field of neurological brain disorders were highlighted during the first part of the workshop. Moreover, speakers illustrated how mHealth tools can better support treatment for patients affected by brain disorders. Successful examples of mHealth tools, such as the app “MyDystonia”, were also presented. The second part of the workshop focused on the potential offered by mHealth for patients with neurological brain disorders. Relevant initiatives carried out by the European Commission were presented, and the importance of involving patients in the designing of new mHealth tools for the treatment of brain disorders was also discussed. This workshop and the respective document were prepared by the Policy Department A at the request of the Committee on Environment, Public Health and Food Safety.

Zunanji avtor

Alojz PETERLE, Linda McAVAN, Nessa CHILDERS, Frédéric DESTREBECQ, Monika BENSON, Nicholas MEYER, Jean-Pierre LIN, Terje PEETSO and Nicola BEDLINGTON

Focus on digital health events

01-06-2016

Digital health is high on the European and international agenda in June 2016, notably during eHealth Week from 8 to 10 June in Amsterdam, at the eHealth360°Summit from 14 to 16 June in Budapest and at the Digital Health World Congress on 22 and 23 June in London.

Digital health is high on the European and international agenda in June 2016, notably during eHealth Week from 8 to 10 June in Amsterdam, at the eHealth360°Summit from 14 to 16 June in Budapest and at the Digital Health World Congress on 22 and 23 June in London.

What if injections weren't needed anymore?

26-11-2015

Synthetic biology is expected to design, construct and develop artificial (i.e. man-made) biological systems that mimic or even go beyond naturally-occurring biological systems. What are the benefits of this emerging field? Are there any ethical and social issues arising from this engineering approach to biology?

Synthetic biology is expected to design, construct and develop artificial (i.e. man-made) biological systems that mimic or even go beyond naturally-occurring biological systems. What are the benefits of this emerging field? Are there any ethical and social issues arising from this engineering approach to biology?

Personalised medicine: The right treatment for the right person at the right time

08-10-2015

'Personalised medicine' refers to a medical approach that uses molecular insights into health and disease to guide decisions with regard to the prediction, prevention, diagnosis and treatment of illnesses. Genetic factors play a role in most human diseases, with gene variations contributing to their incidence or course. New tools harnessed by personalised medicine include '-omics' technologies, which seek to define and explain the molecular mechanisms of the human body, and biomarkers, allowing us ...

'Personalised medicine' refers to a medical approach that uses molecular insights into health and disease to guide decisions with regard to the prediction, prevention, diagnosis and treatment of illnesses. Genetic factors play a role in most human diseases, with gene variations contributing to their incidence or course. New tools harnessed by personalised medicine include '-omics' technologies, which seek to define and explain the molecular mechanisms of the human body, and biomarkers, allowing us to subdivide patients into groups according to their likely response to a specific treatment, and so decide on the best-suited medication. Integrating advances in molecular technology into clinical practice comes with challenges, namely the translational gap, data protection, regulatory clarity and cost. Moreover, it is considered essential to educate patients (to acquire health literacy) as well as healthcare professionals (both in terms of providing them with undergraduate education and with continuous opportunities to advance their skills). EU initiatives in the field of personalised medicine include the Innovative Medicines Initiative (IMI), financial support to major research projects, and participation in international consortia. The Luxembourg Council Presidency has made personalised medicine one of its health priorities.

Prihajajoči dogodki

01-12-2020
FISC Public Hearing on 1st December 2020
Predstavitev -
FISC
01-12-2020
Inter-parliamentary Committee meeting on the Evaluation of Eurojust Activities
Drug dogodek -
LIBE
02-12-2020
Public Hearing on AI and Health
Predstavitev -
AIDA

Partnerji